Discover
PEN
Penumbra, Inc.
316.43
40 x undefined
80 x undefined
bid
ask
+
0.68
0.22%
60 @ 04:00 PM
316.43 +0.00 (0.00%)
| Ytd | 1.78% | |
| 1y | 26.23% |
315.86
day range
317.10
221.26
52 week range
362.41
| Open | 315.26 | Prev Close | 315.75 | Low | 315.86 | High | 317.10 | Mkt Cap | 12.45B |
| Vol | 419.15K | Avg Vol | 458.14K | EPS | 4.34 | P/E | 72.91 | Forward P/E | 50.44 |
| Beta | 0.70 | Short Ratio | 4.47 | Inst. Own | 87.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-28 | 50-d Avg | 322.10 | 200-d Avg | 309.00 | 1yr Est | 364.43 |
PEN News
benzinga.com
RBC Capital Reiterates Sector Perform on Penumbra, Maintains $374 Price Target
RBC Capital analyst Shagun Singh reiterates Penumbra (NYSE:PEN) with a Sector Perform and maintai
benzinga.com
Penumbra's THUNDERBOLT Gets FDA Clearance To Treat Acute Ischemic Stroke
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced it has received